argenx SE | ARGX - Debt

Stock Price
680.60
Daily Change
-12.60 -1.82%
Monthly
-3.82%
Yearly
34.24%
Q2 Forecast
678.23

argenx SE reported $47.16M in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
AstraZeneca USD 33.92B 4.3B Mar/2026
Genmab DKK 148M 5M Jun/2025
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
GRIFOLS EUR 9.57B 746.56M Dec/2025
Hikma Pharmaceutical USD 1.56B 252M Jun/2025
Lakefront Biotherapeutics EUR 6.44M 480K Mar/2026
Qiagen NV USD 1.81B 314.82M Dec/2025
UCB EUR 3.03B 12M Dec/2024